Showing results (321-330 of 5,474) with videos related to
Sort By:
Pageof 548
International Journal of Hematology|January 26, 2022
Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case reportFuko Kawahara, Rie Shirayama, Takuma Ito, et al.International Journal of Hematology|January 31, 2022
Bowel wall thickness is a strong predictor of steroid-refractory acute graft-versus-host disease with gut involvement after allo-HSCTMikhail Drokov, Galina Yatsyk, Anna Kireeva, et al.International Journal of Hematology|March 11, 2022
Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disordersYasushi Onishi, Koichi Onodera, Noriko Fukuhara, et al.International Journal of Hematology|March 11, 2022
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidineAkihito Matsuoka, Masaki Tanibuchi, Ieharu Yamazaki, et al.International Journal of Hematology|March 26, 2022
Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosisWanying Cheng, Xin Gao, Guangli Yin, et al.International Journal of Hematology|April 8, 2022
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapyChikashi Yoshida, Takeshi Kondo, Tomoki Ito, et al.International Journal of Hematology|April 8, 2022
Treatment options and pregnancy management for patients with PV and ETYoko EdahiroInternational Journal of Hematology|March 22, 2022
COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine stormYoshihiro Fujimura, Linda Z HollandInternational Journal of Hematology|March 30, 2022
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectivesGiuseppe G Loscocco, Alessandro M VannucchiInternational Journal of Hematology|September 22, 2018
Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantationMakoto Nakamura, Nobuharu Fujii, Kazuyoshi Shimizu, et al.Pageof 548